Perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation: a case report and literature review / 药学实践杂志
Journal of Pharmaceutical Practice
; (6): 372-373, 2022.
Article
в Zh
| WPRIM
| ID: wpr-935040
Ответственная библиотека:
WPRO
ABSTRACT
Objective To explore the strategies of perioperative antithrombotic therapy in the patient undergoing revision total hip arthroplasty after coronary stent implantation. Methods The antithrombotic therapy in one patient undergoing revision total hip arthroplasty after coronary stent implantation was analyzed with the review of related literatures. Results The patient developed non-ST segment elevated myocardial infarction due to the stop of aspirin three days before operation and no low molecular weight heparin was used. The antithrombotic treatment and prevention of venous thromboembolism were analyzed. Conclusion Antithrombotic therapy should be selected reasonably in patients undergoing revision total hip arthroplasty after coronary stent implantation.
Полный текст:
1
База данных:
WPRIM
Язык:
Zh
Журнал:
Journal of Pharmaceutical Practice
Год:
2022
Тип:
Article